Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2017 | 12-2006 | 12-2005 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,617 | N/A | N/A | N/A | -5,530 |
| Depreciation Amortization | 46 | N/A | N/A | N/A | 3,100 |
| Income taxes - deferred | 165 | N/A | N/A | N/A | N/A |
| Accounts receivable | 95 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -62 | N/A | N/A | N/A | N/A |
| Other Working Capital | 445 | N/A | N/A | N/A | 10,420 |
| Other Operating Activity | -1,323 | 0 | 0 | 0 | 260 |
| Operating Cash Flow | $-7,251 | $N/A | $N/A | $N/A | $8,250 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | N/A | N/A | N/A | -3,510 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -11,910 |
| Investing Cash Flow | $-3 | $N/A | $N/A | $N/A | $-15,420 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,002 | N/A | N/A | N/A | N/A |
| Debt Repayment | -533 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 3,703 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -139 | 0 | 0 | 0 | 110,540 |
| Financing Cash Flow | $6,033 | $N/A | $N/A | $N/A | $110,540 |
| Exchange Rate Effect | -5 | N/A | N/A | N/A | 0 |
| Beginning Cash Position | 1,524 | N/A | N/A | N/A | 3,240 |
| End Cash Position | 298 | N/A | N/A | N/A | 106,620 |
| Net Cash Flow | $-1,226 | $N/A | $N/A | $N/A | $103,370 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,251 | N/A | N/A | N/A | 8,250 |
| Capital Expenditure | -3 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -7,254 | 0 | 0 | 0 | 8,250 |